Dr. Gautam Subbaiah Kalyatanda, MD

Dr. Kalyatanda practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Kalyatanda's NPI, 1669784450, was assigned on July 8, 2010. Dr. Kalyatanda graduated from JSS Medical College Mysore in 2001. Dr. Kalyatanda holds Florida license ME128695.

Dr. Kalyatanda's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Kalyatanda's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Kalyatanda to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalyatanda practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Kalyatanda's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Kalyatanda is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Kalyatanda's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists acute skin infection, gastrointestinal infection, joint or bone infection, pneumonia, pneumonia and respiratory infection, urinary tract infection and UTI among the conditions Dr. Kalyatanda treats.

CMS data shows 350 Medicare services from Dr. Kalyatanda across 9 procedure codes in 2024, for 173 Medicare patients. Medicare paid $32,804 for them.

CMS counts 173 Medicare patients who saw Dr. Kalyatanda in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalyatanda's median patient age at 72, with 51% women.

In 2024, Dr. Kalyatanda wrote 362 Medicare Part D claims for 54 patients. 78% of them were for generic drugs. CMS names the drug for 301 of them, across 13 drugs with 11 or more claims each, at $449,051 in total drug cost. In 2023, CMS named 185 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Kalyatanda for performance year 2024, reported through an alternative payment model (APM). Dr. Kalyatanda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalyatanda as offering telehealth.

Dmand AI links 16 papers to Dr. Kalyatanda, published from 2017 to 2025. 2023 was the busiest year, with 5. Dr. Kalyatanda has published most often in Cureus. Dr. Kalyatanda's most frequent co-authors are Lennox Archibald, MD, Vidya Sagar Kollu, MD and Anthony Paul Cannella, MD.

Dr. Kalyatanda graduated from JSS Medical College Mysore in 2001.

Dr. Kalyatanda is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.